In simple terms, Vascular Biogenics Ltd. has 77.64 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.971% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -114.530%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -21.189%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust -0.511% return, is a testament to Vascular Biogenics Ltd.'s adeptness in optimizing resource deployment. Vascular Biogenics Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.579%. Furthermore, the proficiency of Vascular Biogenics Ltd. in capital utilization is underscored by a remarkable -3.517% return on capital employed.
Stock Prices
Vascular Biogenics Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.219, while its low point bottomed out at $0.2036. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Vascular Biogenics Ltd.'s stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
